Signaling Pathways in Schizophrenia: emerging targets and therapeutic strategies

Dopamine D(2) receptor antagonism is a unifying property of all antipsychotic drugs in clinical use for schizophrenia. While often effective at ameliorating psychosis, these drugs are largely ineffective at treating negative and cognitive symptoms. Increasing attention is being focused on the comple...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Karam, Caline S, Ballon, Jacob S, Bivens, Nancy M, Freyberg, Zachary, Girgis, Ragy R, Lizardi-Ortiz, Jose E, Markx, Sander, Lieberman, Jeffrey A, Javitch, Jonathan A
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3635536/
https://ncbi.nlm.nih.gov/pubmed/20579747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2010.05.004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge